2024-11-17 – BE&O A&B
Despite the success of its new weight loss drug Zepbound, Lilly’s recent earnings failed to meet expectations.
Shares of Lilly took a hit as Q3 earnings didn’t satisfy Wall Street. With a total revenue of over $7.8 billion, an increase of 46% over the same period last year, market expectations were higher for the Indiana-based drug manufacturer.
Goldman Sachs has announced that it is bringing its business initiative program to Central Indiana. The program will help businesses with marketing, location growth, and adding revenue sources. Goldman Sachs will also utilize community partners to provide small business owners with advice on day-to-day operations…